374 related articles for article (PubMed ID: 32402505)
21. Association of MMP-2 expression and prognosis in osteosarcoma patients.
Zhang M; Zhang X
Int J Clin Exp Pathol; 2015; 8(11):14965-70. PubMed ID: 26823829
[TBL] [Abstract][Full Text] [Related]
22. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of the microRNA-29 family in patients with primary osteosarcomas.
Hong Q; Fang J; Pang Y; Zheng J
Med Oncol; 2014 Aug; 31(8):37. PubMed ID: 25015394
[TBL] [Abstract][Full Text] [Related]
25. SLC19A1 May Serve as a Potential Biomarker for Diagnosis and Prognosis in Osteosarcoma.
Li C; Yuan B; Yu X; Ju L; Ma Y; Guo D; Zhang K
Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180421
[TBL] [Abstract][Full Text] [Related]
26. Identification of serum microRNA-21 as a biomarker for chemosensitivity and prognosis in human osteosarcoma.
Yuan J; Chen L; Chen X; Sun W; Zhou X
J Int Med Res; 2012; 40(6):2090-7. PubMed ID: 23321165
[TBL] [Abstract][Full Text] [Related]
27. Circular RNA circ-NT5C2 acts as a potential novel biomarker for prognosis of osteosarcoma.
Nie WB; Zhao LM; Guo R; Wang MX; Ye FG
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6239-6244. PubMed ID: 30338784
[TBL] [Abstract][Full Text] [Related]
28. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
Wang Z; Cai H; Lin L; Tang M; Cai H
Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
[TBL] [Abstract][Full Text] [Related]
29. High CCL5 expression is associated with osteosarcoma metastasis and poor prognosis of patients with osteosarcoma.
Sun K; Gong C; Peng H; Fang H; Zhou J; Li J; Chen S; Zheng H
Mol Med Rep; 2017 Nov; 16(5):6953-6957. PubMed ID: 28901496
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of Twist and E-cadherin in patients with osteosarcoma.
Yin K; Liao Q; He H; Zhong D
Med Oncol; 2012 Dec; 29(5):3449-55. PubMed ID: 22847601
[TBL] [Abstract][Full Text] [Related]
31. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.
Zou P; Ding J; Fu S
Pathol Res Pract; 2017 Mar; 213(3):194-198. PubMed ID: 28214202
[TBL] [Abstract][Full Text] [Related]
32. Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma.
Li RZ; Wang LM
World J Surg Oncol; 2016 May; 14():150. PubMed ID: 27193084
[TBL] [Abstract][Full Text] [Related]
33. High levels of long non-coding RNA DICER1-AS1 are associated with poor clinical prognosis in patients with osteosarcoma.
Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7640-7645. PubMed ID: 30536305
[TBL] [Abstract][Full Text] [Related]
34. A Four-Pseudogene Classifier Identified by Machine Learning Serves as a Novel Prognostic Marker for Survival of Osteosarcoma.
Liu F; Xing L; Zhang X; Zhang X
Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146489
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic significance and prognostic value of circRNAs in osteosarcoma: a systematic review and meta-analysis.
Zhong J; Zhang G; Yao W
J Orthop Surg Res; 2021 Oct; 16(1):578. PubMed ID: 34620208
[TBL] [Abstract][Full Text] [Related]
36. Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
Li Q; Song S; Ni G; Li Y; Wang X
Cancer Biomark; 2018 Feb; 21(3):521-526. PubMed ID: 29103020
[TBL] [Abstract][Full Text] [Related]
37. Decreased expression of STAT5A predicts poor prognosis in osteosarcoma.
Guo Z; Tang Y; Fu Y; Wang J
Pathol Res Pract; 2019 Mar; 215(3):519-524. PubMed ID: 30638860
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
Li X; Yang H; Tian Q; Liu Y; Weng Y
Neoplasma; 2014; 61(4):453-60. PubMed ID: 24645838
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic significance of S100A4 expression in osteosarcoma.
Cao CM; Yang FX; Wang PL; Yang QX; Sun XR
Eur Rev Med Pharmacol Sci; 2014; 18(6):833-9. PubMed ID: 24706307
[TBL] [Abstract][Full Text] [Related]
40. Reduced expression of miR-564 is associated with worse prognosis in patients with osteosarcoma.
Gao F; Xu F
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5851-5856. PubMed ID: 30280765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]